These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 19758186)
1. Toll-like receptors in multiple sclerosis mouse experimental models. Marta M Ann N Y Acad Sci; 2009 Sep; 1173():458-62. PubMed ID: 19758186 [TBL] [Abstract][Full Text] [Related]
2. Regulation of autoimmune encephalomyelitis by toll-like receptors. Marta M; Meier UC; Lobell A Autoimmun Rev; 2009 May; 8(6):506-9. PubMed ID: 19211042 [TBL] [Abstract][Full Text] [Related]
3. Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation. Derkow K; Krüger C; Dembny P; Lehnardt S PLoS One; 2015; 10(8):e0135898. PubMed ID: 26288016 [TBL] [Abstract][Full Text] [Related]
4. 15-deoxy-Delta(12,14)-prostaglandin J(2) and curcumin modulate the expression of toll-like receptors 4 and 9 in autoimmune T lymphocyte. Chearwae W; Bright JJ J Clin Immunol; 2008 Sep; 28(5):558-70. PubMed ID: 18463970 [TBL] [Abstract][Full Text] [Related]
5. MyD88-dependent and -independent murine cytomegalovirus sensing for IFN-alpha release and initiation of immune responses in vivo. Delale T; Paquin A; Asselin-Paturel C; Dalod M; Brizard G; Bates EE; Kastner P; Chan S; Akira S; Vicari A; Biron CA; Trinchieri G; Brière F J Immunol; 2005 Nov; 175(10):6723-32. PubMed ID: 16272328 [TBL] [Abstract][Full Text] [Related]
6. Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis. Marta M; Andersson A; Isaksson M; Kämpe O; Lobell A Eur J Immunol; 2008 Feb; 38(2):565-75. PubMed ID: 18203139 [TBL] [Abstract][Full Text] [Related]
7. Delineating the Role of Toll-Like Receptors in the Neuro-inflammation Model EAE. Fallarino F; Gargaro M; Mondanell G; Downer EJ; Hossain MJ; Gran B Methods Mol Biol; 2016; 1390():383-411. PubMed ID: 26803641 [TBL] [Abstract][Full Text] [Related]
8. Fcγ receptors and toll-like receptor 9 synergize to drive immune complex-induced dendritic cell maturation. Nelson NLJ; Zajd CM; Lennartz MR; Gosselin EJ Cell Immunol; 2019 Nov; 345():103962. PubMed ID: 31582169 [TBL] [Abstract][Full Text] [Related]
9. Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity. Su SB; Silver PB; Grajewski RS; Agarwal RK; Tang J; Chan CC; Caspi RR J Immunol; 2005 Nov; 175(10):6303-10. PubMed ID: 16272281 [TBL] [Abstract][Full Text] [Related]
11. MyD88-dependent and -independent signalling via TLR3 and TLR4 are differentially modulated by Δ Fitzpatrick JM; Minogue E; Curham L; Tyrrell H; Gavigan P; Hind W; Downer EJ J Neuroimmunol; 2020 Jun; 343():577217. PubMed ID: 32244040 [TBL] [Abstract][Full Text] [Related]
12. GPR108, an NF-κB activator suppressed by TIRAP, negatively regulates TLR-triggered immune responses. Dong D; Zhou H; Na SY; Niedra R; Peng Y; Wang H; Seed B; Zhou GL PLoS One; 2018; 13(10):e0205303. PubMed ID: 30332431 [TBL] [Abstract][Full Text] [Related]
13. Role for MyD88, TLR2 and TLR9 but not TLR1, TLR4 or TLR6 in experimental autoimmune encephalomyelitis. Miranda-Hernandez S; Gerlach N; Fletcher JM; Biros E; Mack M; Körner H; Baxter AG J Immunol; 2011 Jul; 187(2):791-804. PubMed ID: 21685327 [TBL] [Abstract][Full Text] [Related]
14. Early IFN-γ production together with decreased expression of TLR3 and TLR9 characterizes EAE development conditional on the presence of myelin. Evangelista MG; Castro SB; Alves CC; Dias AT; Souza VW; Reis LB; Silva LC; Castañon MC; Farias RE; Juliano MA; Ferreira AP Autoimmunity; 2016 Jun; 49(4):258-67. PubMed ID: 26911613 [TBL] [Abstract][Full Text] [Related]
15. TLR4-RelA-miR-30a signal pathway regulates Th17 differentiation during experimental autoimmune encephalomyelitis development. Qu X; Han J; Zhang Y; Wang X; Fan H; Hua F; Yao R J Neuroinflammation; 2019 Sep; 16(1):183. PubMed ID: 31561751 [TBL] [Abstract][Full Text] [Related]
16. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm. Batoulis H; Addicks K; Kuerten S Ann Anat; 2010 Aug; 192(4):179-93. PubMed ID: 20692821 [TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 2 signaling in CD4(+) T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease. Reynolds JM; Pappu BP; Peng J; Martinez GJ; Zhang Y; Chung Y; Ma L; Yang XO; Nurieva RI; Tian Q; Dong C Immunity; 2010 May; 32(5):692-702. PubMed ID: 20434372 [TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation. Reynolds JM; Martinez GJ; Chung Y; Dong C Proc Natl Acad Sci U S A; 2012 Aug; 109(32):13064-9. PubMed ID: 22826216 [TBL] [Abstract][Full Text] [Related]
19. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. Bellocchio S; Montagnoli C; Bozza S; Gaziano R; Rossi G; Mambula SS; Vecchi A; Mantovani A; Levitz SM; Romani L J Immunol; 2004 Mar; 172(5):3059-69. PubMed ID: 14978111 [TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor interactions: tolerance of MyD88-dependent cytokines but enhancement of MyD88-independent interferon-beta production. Broad A; Kirby JA; Jones DE; Immunology; 2007 Jan; 120(1):103-11. PubMed ID: 17034424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]